Common use of Entry of Biosimilar Products Clause in Contracts

Entry of Biosimilar Products. If, in any Region in the Licensed Territory during the Royalty Term for a Product, one or more Biosimilar Products to such Product are sold by any Third Party in such Region for [***], and sales of such Biosimilar Product(s) during each such [***] represent at least [***] of the total sales in such Region on a unit basis (as measured against the total sales of such Product and Biosimilar Products in such Region), then the then-applicable royalty rates for such [***] for such Product in such Region will be reduced by [***].

Entry of Biosimilar Products. If, in any Region in the Licensed Territory during the Royalty Term for a Product, one or more Biosimilar Products to such Product are sold by any Third Party in such Region the Territory for [***], and sales of such Biosimilar Product(s) during each such [***] represent at least [***] of the total sales in such Region the Territory on a unit basis (as measured against the total sales of such Product and Biosimilar Products in such Regionthe Territory), then the then-applicable royalty rates for such [***] for such Product in such Region the Territory will be reduced by [***].